PUBLISHER: TechNavio | PRODUCT CODE: 1801561
PUBLISHER: TechNavio | PRODUCT CODE: 1801561
The digital biomarkers market is forecasted to grow by USD 5,815.1 mn during 2024-2029, accelerating at a CAGR of 22.4% during the forecast period. The report on the digital biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, increasing prevalence of cvds, and increasing adoption of smart wearables.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 21% |
CAGR | 22.4% |
Incremental Value | $5,815.1 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's digital biomarkers market is segmented as below:
By Type
By End-user
By Platform
By Geographical Landscape
This study identifies the increasing focus on personalized treatments as one of the prime reasons driving the digital biomarkers market growth during the next few years. Also, increasing number of clinical trials in countries and growing demand for remote health monitoring will lead to sizable demand in the market.
The report on the digital biomarkers market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading digital biomarkers market vendors that include Altoida Inc, APPLICARE.AI, Aural Analytics Inc, Brainomix Ltd., Chugai Pharmaceutical Co. Ltd., Clario, Clinical Ink Inc., Empatica Inc, F. Hoffmann La Roche Ltd., Google LLC, IMVARIA Inc., Invitrace, IQVIA Holdings Inc., IXICO PLC, Koneksa Health Inc., Neurotrack Technologies Inc., PureTech Health PLC, and VivoSense Inc.. Also, the digital biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: